A randomized, double-blind, parallel, single dose comparative pharmacokinetic study of two humanized monoclonal antibodies targeting HER2 receptors (i.e. trastuzumab) in healthy adult male subjects
Latest Information Update: 26 Apr 2022
At a glance
- Drugs Trastuzumab (Primary)
- Indications Gastric cancer; Male breast cancer
- Focus Pharmacokinetics
- Acronyms TZ-01-003
- Sponsors Dr Reddys Laboratories
- 17 Nov 2016 Status changed from not yet recruiting to completed.
- 04 Jul 2016 New trial record